High-Throughput Discovery of Oligonucleotide Therapeutics in Primary Cells (ISSX 2025 Breakfast Symposium)

At ISSX 2025 in Chicago, Dr. Julius Judd from Korro Bio presented at a breakfast symposium sponsored by Discovery Life Sciences. He shared how Korro’s OPERA® platform uses CHORD™ technology to edit RNA with the body’s own ADAR protein. Watch this video to learn more.